Alliancebernstein L.P. Alector, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Alector, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 711,545 shares of ALEC stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

711,545

Previous 766,973 7.23%

Holding current value

$2.8 Million

Previous $3.48 Million 4.6%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $240,557 - $364,716	-55,428 Reduced 7.23%	711,545 $3.32 Million
Q2 2024 Aug 14, 2024	BUY	$4.19 - $6.23 $172,992 - $257,218	41,287 Added 5.69%	766,973 $3.48 Million
Q1 2024 May 14, 2024	BUY	$5.69 - $8.08 $1.33 Million - $1.89 Million	233,401 Added 47.41%	725,686 $4.37 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $613,243 - $1.36 Million	162,664 Added 49.35%	492,285 $3.93 Million
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $701,641 - $1.18 Million	134,931 Added 69.31%	329,621 $2.14 Million
Q2 2023 Aug 15, 2023	BUY	$5.86 - $7.93 $87,355 - $118,212	14,907 Added 8.29%	194,690 $1.17 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $714,185 - $1.2 Million	122,083 Added 211.58%	179,783 $1.11 Million
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $688,000 - $955,000	-100,000 Reduced 63.41%	57,700 $532,000
Q3 2022 Nov 15, 2022	BUY	$8.19 - $13.2 $778,050 - $1.25 Million	95,000 Added 151.52%	157,700 $1.49 Million
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $573,750 - $1.07 Million	-75,000 Reduced 54.47%	62,700 $637,000
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $306,191 - $488,683	-23,517 Reduced 14.59%	137,700 $1.96 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $1.1 Million - $1.46 Million	57,075 Added 54.8%	161,217 $3.33 Million
Q3 2021 Nov 10, 2021	BUY	$21.65 - $39.49 $1.02 Million - $1.87 Million	47,342 Added 83.35%	104,142 $2.38 Million
Q2 2021 Jul 30, 2021	BUY	$15.5 - $22.48 $105,400 - $152,864	6,800 Added 13.6%	56,800 $1.18 Million
Q1 2021 May 06, 2021	SELL	$14.84 - $22.23 $20,776 - $31,122	-1,400 Reduced 2.72%	50,000 $1.01 Million
Q4 2020 Feb 08, 2021	SELL	$9.4 - $16.7 $109,980 - $195,390	-11,700 Reduced 18.54%	51,400 $778,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $98,021 - $232,128	-9,300 Reduced 12.85%	63,100 $665,000
Q2 2020 Aug 13, 2020	BUY	$21.87 - $33.11 $809,190 - $1.23 Million	37,000 Added 104.52%	72,400 $1.77 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $86,125 - $186,984	5,300 Added 17.61%	35,400 $854,000
Q4 2019 Feb 18, 2020	BUY	$14.17 - $20.3 $79,352 - $113,680	5,600 Added 22.86%	30,100 $519,000
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $141,316 - $217,560	9,800 Added 66.67%	24,500 $353,000
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $239,022 - $388,374	14,700 New	14,700 $279,000

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $325M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Alector, Inc. Transaction History